Möchten Sie immer auf dem neuesten Stand bleiben?

Company announcement – No. 39/2021 Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific Sessions Company to present six...

Company announcement – No. 38 / 2021 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...

Company announcement – No. 37 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. June 10, 2021 – Zealand Pharma...

Company announcement – No. 36/ 2021 Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference Copenhagen, DK and Boston, MA, U.S. June 3, 2021 – Zealand Pharma...

Company announcement – No. 35/ 2021 Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH FDA’s Fast Track Designation for the...

Company announcement – No. 34 / 2021 Total number of shares and voting rights in Zealand Pharma at May 31, 2021 Copenhagen, DK and Boston, MA, May 31, 2021 – Zealand Pharma A/S (“Zealand”)...

Company announcement – No. 34 / 2021 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...

Company announcement – No. 33 / 2021 Zealand Pharma launches long-term incentive program for Zealand’s US based Corporate Management for 2021 Copenhagen, DK and Boston, MA, U.S., May 27, 2021 –...

Company announcement – No. 32/ 2021 Zealand Pharma to participate in Jefferies Virtual Healthcare Conference Copenhagen, DK and Boston, MA, U.S. May 26, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL)...

Company announcement – No. 31/ 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S., May 20, 2021 – Zealand...